• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

欧洲关于骨髓纤维化分级及细胞计数评估的共识

European consensus on grading bone marrow fibrosis and assessment of cellularity.

作者信息

Thiele Jürgen, Kvasnicka Hans Michael, Facchetti Fabio, Franco Vito, van der Walt Jon, Orazi Attilio

机构信息

Institute for Pathology, University of Cologne, Germany.

出版信息

Haematologica. 2005 Aug;90(8):1128-32.

PMID:16079113
Abstract

Quantification of characteristic bone marrow biopsy features includes basic parameters such as cellularity and fiber content. These are important to assess the dynamics of disease processes with a significant impact on risk stratification, survival patterns and, especially, therapy-related changes. A panel of experienced European pathologists and a foreign expert evaluated, at a multi-headed microscope, a large number of representative slides of trephine biopsies from patients with myelofibrosis in an attempt to reach a consensus on how to grade cellularity and fibrosis. This included a critical evaluation of previously described scoring systems. During the microscopic analysis and subsequent discussion and voting, the importance of age-dependent decrease in cellularity was recognized. Grading of myelofibrosis was simplified by using four easily reproducible categories including differentiation between reticulin and collagen. A consensus was reached that the density of fibers must be assessed in relation to the hematopoietic tissue. This feature is especially important in order to avoid a false impression of a reduced fiber content in fatty and/or edematous bone marrow samples after treatment. The consensus for measuring myelofibrosis by clear and reproducible guidelines achieved by our group should allow for precise grading during the disease process and after therapy.

摘要

特征性骨髓活检特征的量化包括细胞密度和纤维含量等基本参数。这些对于评估疾病进程的动态变化很重要,对风险分层、生存模式,尤其是与治疗相关的变化有重大影响。一组经验丰富的欧洲病理学家和一位外国专家在多头显微镜下评估了大量骨髓纤维化患者的环钻活检代表性切片,试图就如何对细胞密度和纤维化进行分级达成共识。这包括对先前描述的评分系统进行批判性评估。在显微镜分析以及随后的讨论和投票过程中,认识到了细胞密度随年龄下降的重要性。通过使用四个易于重复的类别简化了骨髓纤维化的分级,包括区分网状纤维和胶原纤维。达成的共识是,必须相对于造血组织评估纤维密度。这一特征尤为重要,以避免在治疗后的脂肪性和/或水肿性骨髓样本中对纤维含量减少产生错误印象。我们小组通过清晰且可重复的指南达成的测量骨髓纤维化的共识,应有助于在疾病过程中和治疗后进行精确分级。

相似文献

1
European consensus on grading bone marrow fibrosis and assessment of cellularity.欧洲关于骨髓纤维化分级及细胞计数评估的共识
Haematologica. 2005 Aug;90(8):1128-32.
2
Myelofibrosis--what's in a name? Consensus on definition and EUMNET grading.骨髓纤维化——名称背后有何含义?关于定义和欧洲骨髓增殖性肿瘤网络(EUMNET)分级的共识
Pathobiology. 2007;74(2):89-96. doi: 10.1159/000101708.
3
Grade of bone marrow fibrosis is associated with relevant hematological findings-a clinicopathological study on 865 patients with chronic idiopathic myelofibrosis.骨髓纤维化分级与相关血液学表现相关——865例慢性特发性骨髓纤维化患者的临床病理研究
Ann Hematol. 2006 Apr;85(4):226-32. doi: 10.1007/s00277-005-0042-8. Epub 2006 Jan 19.
4
Relevance and dynamics of myelofibrosis regarding hematopoietic reconstitution after allogeneic bone marrow transplantation in chronic myelogenous leukemia--a single center experience on 160 patients.异基因骨髓移植后慢性髓性白血病造血重建中骨髓纤维化的相关性及动态变化——160例患者的单中心经验
Bone Marrow Transplant. 2000 Aug;26(3):275-81. doi: 10.1038/sj.bmt.1702505.
5
Grading of marrow fibrosis in chronic myeloid leukemia--a comprehensive approach.慢性髓性白血病中骨髓纤维化的分级——一种综合方法。
Indian J Pathol Microbiol. 2005 Jul;48(3):341-4.
6
Follow-up study on bone marrow reticulin fibrosis in AML.急性髓系白血病骨髓网硬蛋白纤维化的随访研究
Anal Cell Pathol. 1991 Jul;3(4):225-31.
7
Prognostic significance of bone marrow reticulin fibres in idiopathic myelofibrosis: evaluation of clinicopathological parameters in a scoring system.骨髓网硬蛋白纤维在原发性骨髓纤维化中的预后意义:评分系统中临床病理参数的评估
Haematologia (Budap). 1994;26(2):75-86.
8
Diagnosis and quantification of bone marrow fibrosis are significantly biased by the pre-staining processing of bone marrow biopsies.骨髓活检的染色前处理对骨髓纤维化的诊断和定量有显著影响。
Histopathology. 2006 Jan;48(2):133-48. doi: 10.1111/j.1365-2559.2005.02302.x.
9
Rapid regression of bone marrow fibrosis after dose-reduced allogeneic stem cell transplantation in patients with primary myelofibrosis.原发性骨髓纤维化患者接受剂量降低的异基因干细胞移植后骨髓纤维化的快速消退
Exp Hematol. 2007 Nov;35(11):1719-22. doi: 10.1016/j.exphem.2007.08.022.
10
Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.组织病理学在急性髓系白血病、骨髓增生异常综合征及骨髓增生异常/骨髓增殖性疾病的诊断与分类中的应用
Pathobiology. 2007;74(2):97-114. doi: 10.1159/000101709.

引用本文的文献

1
Differentiating primary bone marrow failure syndromes in children: a retrospective analysis of early clinical and laboratory features.儿童原发性骨髓衰竭综合征的鉴别诊断:早期临床和实验室特征的回顾性分析
Front Pediatr. 2025 Jun 5;13:1557212. doi: 10.3389/fped.2025.1557212. eCollection 2025.
2
Addition of navitoclax to ruxolitinib for patients with myelofibrosis with progression or suboptimal response.对于进展期或反应欠佳的骨髓纤维化患者,在芦可替尼基础上加用维奈托克。
Blood Neoplasia. 2024 Nov 2;2(1):100056. doi: 10.1016/j.bneo.2024.100056. eCollection 2025 Feb.
3
Extreme Thrombocytosis in Patients with Overt Myelofibrosis and Its Clinical Associations.
明显骨髓纤维化患者的极端血小板增多症及其临床关联
Cancers (Basel). 2025 Apr 22;17(9):1390. doi: 10.3390/cancers17091390.
4
Eltrombopag in combination with immunosuppressive therapy in pediatric severe aplastic anemia: phase 2 ESCALATE trial.艾曲泊帕联合免疫抑制疗法治疗儿童重型再生障碍性贫血:2期ESCALATE试验
Blood Adv. 2025 Aug 12;9(15):3728-3738. doi: 10.1182/bloodadvances.2024015102.
5
Rapid Development of Unclassified Myeloid Lineage Acute Leukaemia With Trisomy 6 and U2AF1 Mutation.伴有6号染色体三体和U2AF1突变的未分类髓系急性白血病的快速进展
J Cell Mol Med. 2025 Mar;29(5):e70461. doi: 10.1111/jcmm.70461.
6
Evolution of WHO diagnostic criteria in "Classical Myeloproliferative Neoplasms" compared with the International Consensus Classification.世界卫生组织(WHO)“经典骨髓增殖性肿瘤”诊断标准与国际共识分类的演变
Blood Cancer J. 2025 Mar 4;15(1):31. doi: 10.1038/s41408-025-01235-7.
7
Reticulin-Free Quantitation of Bone Marrow Fibrosis in MPNs: Utility and Applications.骨髓增殖性肿瘤中无网硬蛋白定量评估骨髓纤维化:效用及应用
EJHaem. 2025 Feb 27;6(2):e70005. doi: 10.1002/jha2.70005. eCollection 2025 Apr.
8
A Case of Myeloproliferative Neoplasm with Eosinophilia Associated with PCM1-JAK2 Rearrangement.一例伴有嗜酸性粒细胞增多的骨髓增殖性肿瘤合并PCM1-JAK2重排
Case Rep Oncol. 2025 Jan 8;18(1):190-197. doi: 10.1159/000542692. eCollection 2025 Jan-Dec.
9
Distribution of different classes of CSF3R mutations and co-mutational pattern in 360 myeloid neoplasia.360例髓系肿瘤中不同类型CSF3R突变的分布及共突变模式
Ann Hematol. 2025 Jan;104(1):263-274. doi: 10.1007/s00277-025-06232-1. Epub 2025 Feb 5.
10
Reconstructing skeletal homeostasis through allogeneic hematopoietic stem cell transplantation in myelofibrosis.通过异基因造血干细胞移植重建骨髓纤维化中的骨骼稳态。
Nat Commun. 2025 Jan 20;16(1):741. doi: 10.1038/s41467-025-55915-w.